These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 1246465)
1. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Kim HW; Leikin SL; Arrobio J; Brandt CD; Chanock RM; Parrott RH Pediatr Res; 1976 Jan; 10(1):75-8. PubMed ID: 1246465 [TBL] [Abstract][Full Text] [Related]
2. Potential of attenuated respiratory syncytial virus vaccine for infants and children. Parrott RH; Kim HW; Brandt CD; Chanock RM Dev Biol Stand; 1975; 28():389-99. PubMed ID: 165119 [TBL] [Abstract][Full Text] [Related]
3. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. Murphy BR; Prince GA; Walsh EE; Kim HW; Parrott RH; Hemming VG; Rodriguez WJ; Chanock RM J Clin Microbiol; 1986 Aug; 24(2):197-202. PubMed ID: 3755730 [TBL] [Abstract][Full Text] [Related]
4. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949 [TBL] [Abstract][Full Text] [Related]
5. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. Karron RA; Wright PF; Belshe RB; Thumar B; Casey R; Newman F; Polack FP; Randolph VB; Deatly A; Hackell J; Gruber W; Murphy BR; Collins PL J Infect Dis; 2005 Apr; 191(7):1093-104. PubMed ID: 15747245 [TBL] [Abstract][Full Text] [Related]
6. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate. Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198 [TBL] [Abstract][Full Text] [Related]
7. Antibody response and avidity of respiratory syncytial virus-specific total IgG, IgG1, and IgG3 in young children. Freitas GR; Silva DA; Yokosawa J; Paula NT; Costa LF; Carneiro BM; Ribeiro LZ; Oliveira TF; Mineo JR; Queiróz DA J Med Virol; 2011 Oct; 83(10):1826-33. PubMed ID: 21837801 [TBL] [Abstract][Full Text] [Related]
9. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914 [TBL] [Abstract][Full Text] [Related]
10. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection. Cautivo KM; Bueno SM; Cortes CM; Wozniak A; Riedel CA; Kalergis AM J Immunol; 2010 Dec; 185(12):7633-45. PubMed ID: 21084664 [TBL] [Abstract][Full Text] [Related]
11. Immunopathology of RSV infection: prospects for developing vaccines without this complication. van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293 [TBL] [Abstract][Full Text] [Related]
14. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection. Johnson TR; Graham BS Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270 [TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus (RSV)-induced airway hyperresponsiveness in allergically sensitized mice is inhibited by live RSV and exacerbated by formalin-inactivated RSV. Peebles RS; Sheller JR; Collins RD; Jarzecka K; Mitchell DB; Graham BS J Infect Dis; 2000 Sep; 182(3):671-7. PubMed ID: 10950758 [TBL] [Abstract][Full Text] [Related]
16. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope. Zeng RH; Gong W; Fan CF; Wang YF; Mei XG Vaccine; 2006 Feb; 24(7):941-7. PubMed ID: 16159685 [TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus and other respiratory viruses during the first 3 months of life promote a local TH2-like response. Kristjansson S; Bjarnarson SP; Wennergren G; Palsdottir AH; Arnadottir T; Haraldsson A; Jonsdottir I J Allergy Clin Immunol; 2005 Oct; 116(4):805-11. PubMed ID: 16210054 [TBL] [Abstract][Full Text] [Related]
19. Lymphocyte transformation response of calves to respiratory syncytial virus. Taylor G; Stott EJ; Thomas LH J Med Virol; 1987 Aug; 22(4):333-44. PubMed ID: 3498008 [TBL] [Abstract][Full Text] [Related]
20. Current status of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccine development: memorandum from a joint WHO/NIAID meeting. Murphy BR; Collins PL Bull World Health Organ; 1997; 75(4):307-13. PubMed ID: 9342889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]